Non-ST-Segment Elevation Myocardial Infarction in Elderly Patients

The world population is aging, and cardiovascular diseases are the leading cause of death in Western countries. 

It is increasingly common to find patients aged 70 or older with non-ST-segment elevation acute myocardial infarction (NSTEMI). However, this group has been excluded from most studies, and there is not enough information to determine whether a conservative approach or invasive studies should be the preferred option.

Researchers conducted a meta-analysis including 1479 patients, half of whom underwent invasive treatment (INV) while the other half received conservative treatment (CON).

The primary endpoint (PEP) was all-cause mortality or myocardial infarction at one year of follow-up.

There were no significant differences in the studied population: the mean age was 84 years and 52% of patients were men; 79% had hypertension, 29% had diabetes, 15% had suffered a stroke, 35% had a previous myocardial infarction, 20% had undergone percutaneous coronary intervention (PCI), 13% had undergone myocardial revasculatization surgery, and 15% had atrial fibrillation.

Read also: QFR Analysis of Coronary Lesions with TAVR.

There were also no differences in the Killip classification at admission; most subjects were in Killip class 1.

The PEP at one year was similar between groups: 24.5% in the INV group and 28.9% in the CON group (95% confidence interval [CI]: 0.63–1.22; P = 0.43). There were no differences in mortality, but patients who received conservative treatment had a higher rate of myocardial infarction (19.1% vs. 12.2%, 95% CI 0.47–0.79; P = 0.0002) and a greater need for urgent revascularization (random-effects model hazard ratio [HR]: 0.41; 95% CI, 0.18–0.95; P = 0.037).

Conclusion

There was no evidence that routine invasive treatment in elderly patients with NSTEMI reduces the risk of all-cause mortality or myocardial infarction within one year compared with conservative treatment. However, there is compelling evidence that invasive treatment reduces the risk of recurrent myocardial infarction or need for urgent revascularization. More research through large-scale studies is needed.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.

Reference: Christos P. Kotanidis, et al. European Heart Journal (2024) 45, 2052–2062 https://doi.org/10.1093/eurheartj/ehae151


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...